Use Of Liraglutide For Weight Loss In Patients With Prior Bariatric Surgery

Volume: 12, Issue: 7, Pages: S157 - S157
Published: Aug 1, 2016
Abstract
Liraglutide, a GLP-1 agonist, was recently approved by the Food and Drug Administration (FDA) for use in the treatment of obesity. A large subset of patients have weight regain after bariatric surgery, but would prefer medical obesity management over revisional surgery. Our study evaluated the efficacy of liraglutide in patients with prior bariatric surgery who experienced either suboptimal weight loss or weight regain after their...
Paper Details
Title
Use Of Liraglutide For Weight Loss In Patients With Prior Bariatric Surgery
Published Date
Aug 1, 2016
Volume
12
Issue
7
Pages
S157 - S157
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.